ARENA PHARMACEUTICALS INC's ticker is ARNA and the CUSIP is 040047607. A total of 172 filers reported holding ARENA PHARMACEUTICALS INC in Q1 2018. The put-call ratio across all filers is 0.43 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $1,393,000 | -50.7% | 14,993 | -68.4% | 0.00% | -57.1% |
| Q3 2021 | $2,828,000 | -52.2% | 47,493 | -45.3% | 0.01% | -56.2% |
| Q2 2021 | $5,919,000 | -43.2% | 86,793 | -42.2% | 0.02% | -44.8% |
| Q1 2021 | $10,422,000 | +82.1% | 150,193 | +101.6% | 0.03% | +93.3% |
| Q4 2020 | $5,723,000 | +25.3% | 74,493 | +22.0% | 0.02% | +15.4% |
| Q3 2020 | $4,568,000 | +147.2% | 61,073 | +30.5% | 0.01% | +160.0% |
| Q1 2018 | $1,848,000 | -51.3% | 46,790 | -58.1% | 0.01% | -50.0% |
| Q4 2017 | $3,798,000 | -3.2% | 111,790 | -27.4% | 0.01% | -9.1% |
| Q3 2017 | $3,924,000 | +102.0% | 153,900 | +33.6% | 0.01% | +83.3% |
| Q2 2017 | $1,943,000 | – | 115,200 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 139,528 | $6,083,000 | 4.46% |
| Eversept Partners, LP | 134,151 | $5,848,984 | 2.68% |
| DAFNA Capital Management LLC | 95,242 | $4,153,000 | 1.94% |
| GREAT POINT PARTNERS LLC | 302,000 | $13,167,000 | 1.82% |
| Atika Capital Management LLC | 190,000 | $8,284,000 | 1.59% |
| Crawford Lake Capital Management, LLC | 205,600 | $8,964,000 | 1.57% |
| Crawford Lake Capital Management, LLC | 205,688 | $8,968,000 | 1.57% |
| Cormorant Asset Management, LP | 450,000 | $19,620,000 | 1.45% |
| SENZAR ASSET MANAGEMENT, LLC | 11,123 | $485,000 | 1.40% |
| Rhenman & Partners Asset Management AB | 284,621 | $12,409,000 | 1.27% |